Effect of AF, olaparib and aurola treatment on immune-related

Potential Therapeutic Targets in Ovarian Cancer: Autophagy and Metabolism

Immune gene pathway expression in olaparib-treated PDX models and in

Frontiers The potential of PARP inhibitors in targeted cancer therapy and immunotherapy

Histologic transformation in lung cancer: when one door shuts, another opens - Yuki Sato, Go Saito, Daichi Fujimoto, 2022

Marlies VERSCHUUREN, PhD Student

Cancers, Free Full-Text

Antioxidants, Free Full-Text

PDF) Auranofin Synergizes with the PARP Inhibitor Olaparib to

Marlies VERSCHUUREN, PhD Student

Marlies VERSCHUUREN, PhD Student